MedPath

Intrapartum Glucose Management Among Women With Gestational Diabetes Mellitus

Not Applicable
Completed
Conditions
Gestational Diabetes Mellitus
Interventions
Other: Standard Protocol for intrapartum glucose management
Other: Experimental Protocol for intrapartum glucose management
Registration Number
NCT02596932
Lead Sponsor
Women and Infants Hospital of Rhode Island
Brief Summary

Gestational Diabetes Mellitus (GDM) is one of the most common medical complications of pregnancy. Neonatal hypoglycemia is a common and well described complication for infants born to mothers with GDM and diabetes mellitus (DM) and studies have linked intrapartum maternal glucose levels with neonatal hypoglycemia. While guidelines exist to guide practitioners in how to best manage intrapartum maternal glucose levels among Type I and and Type II DM, there is a paucity of data guiding practitioners in the intrapartum management of blood glucose levels for women with GDM, particularly those treated with insulin antepartum. The goal of this project is to compare two protocols of intrapartum glucose management in women with GDM and investigate the impact on neonatal blood glucose levels.

Detailed Description

Research objective- To compare "Tight" vs. "Less Tight" intrapartum glucose management

Hypothesis: Neonates born to mothers managed via the "Less Tight" intrapartum glucose management protocol will have lower mean glucose levels in the first 24 hours of life when compared to mean glucose levels among infants born to mothers managed via the "Tight" intrapartum glucose management protocol.

Study Design: Randomized trial

Population: English or Spanish speaking women with a diagnosis of GDM managed at the Diabetes in Pregnancy Program at Women \& Infants Hospital, with a plan to deliver at Women \& Infants Hospital

Once enrolled, patients will then be randomized to "Tight" or "Less Tight" intrapartum glucose control.

Once admitted to the labor floor for intrapartum management the appropriate power plan for glucose control will be initiated. The specifics of labor management will be left to the discretion of the provider.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
76
Inclusion Criteria
  • English or Spanish speaking women with a diagnosis of GDM managed at the Diabetes in Pregnancy Program at Women & Infants Hospital, with a plan to deliver at Women & Infants Hospital
Exclusion Criteria
  • Pre-existing DM, multiple gestations, major fetal anomalies anticipated to require NICU admission, planned cesarean delivery, medications known to effect glucose metabolism other than insulin (i.e. metformin)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Tight controlStandard Protocol for intrapartum glucose managementIntervention Standard Care: Tight glucose control protocol: Goal maternal blood glucose 70-100, q 1 hour blood glucose checks, insulin treatment started with single maternal blood glucose level \> 100mg/dL or \< 60 mg/dL
Less tight controlExperimental Protocol for intrapartum glucose managementIntervention: Less Tight glucose control protocol: Goal maternal blood glucose 70-120, q 4 hour blood glucose checks (unless symptomatic), insulin treatment started with single maternal blood glucose \> 120 mg/dL or \< 60mg/dL
Primary Outcome Measures
NameTimeMethod
Mean neonatal blood glucose levels24 hours
Secondary Outcome Measures
NameTimeMethod
Neonatal Intensive Care Unit (NICU) admissionBirth of neonate until time of discharge of neonate to home up to 7 days

Any admission to Neonatal Intensive Care Unit from moment of birth of neonate until time of discharge of neonate to home

Hours in Neonatal Intensive Care Unit (NICU)Birth of neonate until time of discharge of neonate to home up to 7 days

Any time spent in Neonatal Intensive Care Unit from moment of birth of neonate until time of discharge of neonate to home

Maternal hypoglycemiaIntrapartum period

Trial Locations

Locations (1)

Women & Infants Hospital Rhode Island

🇺🇸

Providence, Rhode Island, United States

© Copyright 2025. All Rights Reserved by MedPath